Pegylated liposomal doxorubicin (Caelyx): contemporary aspects of its application in hematology
.
Saved in:
Main Authors: | O. A. Rukavitsin, V. P. Pop |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2022-11-01
|
Series: | Онкогематология |
Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/698 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Place of pegylated liposomal doxorubicin in the therapy of metastatic breast cancer
by: E. V. Artamonova
Published: (2016-09-01) -
Enhancing targeted delivery and efficacy of PEGylated liposomal doxorubicin with liposomal minoxidil: comprehensive in silico, in vitro, and in vivo tumor model studies
by: Vahideh Mohammadzadeh, et al.
Published: (2025-12-01) -
Long-term effect of pegylated liposomal doxorubicin in recurrent platinum-resistant ovarian cancer: а clinical case
by: I. A. Pokataev, et al.
Published: (2015-11-01) -
In Vitro Study of Antitumor and Antimicrobial Activity of a Preparation of Pegylated Liposomes with Sanguinarine
by: S. V. Lutsenko, et al.
Published: (2020-05-01) -
Matrix Metalloproteinase-2-Responsive Peptide-Modified Cleavable PEGylated Liposomes for Paclitaxel Delivery
by: Xingyu Zhao, et al.
Published: (2025-07-01)